HansBiomed Corporation (KOSDAQ:042520)
South Korea
· Delayed Price · Currency is KRW 28,200
+50 (0.18%)
At close: Dec 5, 2025
HansBiomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Market Capitalization | 366,233 | 127,792 | 207,570 | 92,964 | 160,691 | 226,346 | Upgrade
|
| Market Cap Growth | 244.74% | -38.43% | 123.28% | -42.15% | -29.01% | 9.48% | Upgrade
|
| Enterprise Value | 398,619 | 153,787 | 241,607 | 132,643 | 187,080 | 248,070 | Upgrade
|
| Last Close Price | 28200.00 | 9840.00 | 17930.00 | 9610.00 | 16050.00 | 22850.00 | Upgrade
|
| PE Ratio | - | - | - | 15.12 | - | - | Upgrade
|
| Forward PE | 34.56 | 20.86 | 20.86 | 20.86 | 20.86 | 20.86 | Upgrade
|
| PS Ratio | 4.28 | 1.58 | 2.66 | 1.25 | 2.72 | 2.83 | Upgrade
|
| PB Ratio | 5.89 | 1.90 | 4.16 | 1.96 | 3.38 | 3.27 | Upgrade
|
| P/TBV Ratio | 5.93 | 1.93 | 4.29 | 2.08 | 3.70 | 3.98 | Upgrade
|
| P/OCF Ratio | - | 72.67 | - | - | - | 39.36 | Upgrade
|
| EV/Sales Ratio | 4.66 | 1.90 | 3.10 | 1.78 | 3.17 | 3.10 | Upgrade
|
| EV/EBITDA Ratio | 233.25 | 25.58 | 231.57 | 21.54 | - | 1203.72 | Upgrade
|
| EV/EBIT Ratio | - | 245.82 | - | 105.60 | - | - | Upgrade
|
| EV/FCF Ratio | -108.68 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.69 | 0.54 | 0.82 | 1.18 | 1.08 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 8.12 | 6.06 | 39.43 | 9.08 | - | 159.38 | Upgrade
|
| Asset Turnover | 0.67 | 0.67 | 0.61 | 0.57 | 0.45 | 0.60 | Upgrade
|
| Inventory Turnover | 1.19 | 1.05 | 1.20 | 1.26 | 1.64 | 2.28 | Upgrade
|
| Quick Ratio | 0.55 | 0.38 | 0.31 | 0.32 | 0.49 | 1.36 | Upgrade
|
| Current Ratio | 1.05 | 0.99 | 0.77 | 0.73 | 0.84 | 2.09 | Upgrade
|
| Return on Equity (ROE) | -15.31% | -13.33% | -49.47% | 10.36% | -37.86% | -23.70% | Upgrade
|
| Return on Assets (ROA) | 0.00% | 0.32% | -2.04% | 0.60% | -9.46% | -1.60% | Upgrade
|
| Return on Capital (ROIC) | 0.00% | 0.40% | -2.67% | 0.78% | -12.28% | -1.94% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.00% | 0.90% | -7.30% | 2.20% | -28.90% | -3.30% | Upgrade
|
| Earnings Yield | -2.72% | -5.65% | -11.10% | 6.61% | -11.38% | -7.88% | Upgrade
|
| FCF Yield | -1.00% | -0.65% | -2.73% | -8.88% | -12.16% | -0.57% | Upgrade
|
| Buyback Yield / Dilution | -2.92% | -20.83% | 18.41% | -31.21% | -1.48% | -0.37% | Upgrade
|
| Total Shareholder Return | -2.92% | -20.83% | 18.41% | -31.21% | -1.48% | -0.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.